Zoetis (ZTS) FCF Payout Ratio Growth (3y) (2015 - 2026)
Zoetis (ZTS) FCF Payout Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 34.17% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -43.00% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 37.03% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.17% |
| Dec 31, 2025 | -5.36% |
| Sep 30, 2025 | -15.43% |
| Jun 30, 2025 | 6.08% |
| Mar 31, 2025 | 9.60% |
| Dec 31, 2024 | -2.21% |
| Sep 30, 2024 | -2.37% |
| Jun 30, 2024 | -8.68% |
| Mar 31, 2024 | 13.23% |
| Dec 31, 2023 | 26.95% |
| Sep 30, 2023 | -24.13% |
| Jun 30, 2023 | -80.72% |
| Mar 31, 2023 | 10.85% |
| Dec 31, 2022 | 90.64% |
| Sep 30, 2022 | 23.90% |
| Jun 30, 2022 | 29.63% |
| Mar 31, 2022 | 27.72% |
| Dec 31, 2021 | 43.66% |
| Sep 30, 2021 | 20.25% |
| Jun 30, 2021 | 9.38% |